Marshall & Sterling Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Marshall & Sterling Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.98K	Hold	71	–	–	0.01%	248
2026 Q1	$9.85K	Sell	71 -23	-24%	-$3.22K	0.01%	233
2025 Q4	$11.6K	Sell	94 -89	-49%	-$10.8K	0.01%	225
2025 Q3	$20.3K	Hold	183	–	–	0.01%	268
2025 Q2	$20.2K	Sell	183 -6	-3%	-$639	0.01%	260
2025 Q1	$21.2K	Buy	189 +120	+174%	+$12.4K	0.01%	245
2024 Q4	$6.31K	Buy	+69	New	+$6.21K	﹤0.01%	247

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Marshall & Sterling Wealth Advisors's GILD Position: Q2 2026 in Review

Marshall & Sterling Wealth Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 71 shares worth $8.98K. The position accounts for 0.01% of the portfolio, ranked #248.

Marshall & Sterling Wealth Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.2K in Q1 2025. 573 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Marshall & Sterling Wealth Advisors held 71 shares of Gilead Sciences worth $8.98K as of Q2 2026.
Marshall & Sterling Wealth Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Marshall & Sterling Wealth Advisors's portfolio in Q2 2026, its #248 holding.
Marshall & Sterling Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Marshall & Sterling Wealth Advisors's Gilead Sciences position peaked at $21.2K in Q1 2025.
573 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.